New antibody cocktail aims to control advanced prostate cancer

NCT ID NCT06095089

First seen Nov 01, 2025 · Last updated May 11, 2026 · Updated 22 times

Summary

This early-phase study tests two experimental drugs (JNJ-87189401 and JNJ-78278343) that help the immune system attack prostate cancer cells. About 355 adults with advanced prostate cancer will take part. The main goal is to find the safest dose and check for side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATIC NEOPLASMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Centre Leon Berard

    RECRUITING

    Lyon, 69008, France

  • Herbert Irving Comprehensive Cancer Center Columbia University Medical Center

    RECRUITING

    New York, New York, 10032, United States

  • Institut Bergonie

    RECRUITING

    Bordeaux, 33000, France

  • Institut Gustave Roussy

    RECRUITING

    Villejuif, 94800, France

  • Oregon Health And Science University

    RECRUITING

    Portland, Oregon, 97239, United States

  • START New Jersey

    RECRUITING

    East Brunswick, New Jersey, 08816, United States

  • Sidney Kimmel Cancer Center - Jefferson Health

    RECRUITING

    Philadelphia, Pennsylvania, 19107, United States

  • South Texas Accelerated Research Therapeutics, LLC (START)

    RECRUITING

    San Antonio, Texas, 78229, United States

  • Swedish Medical Center

    RECRUITING

    Seattle, Washington, 98104, United States

  • Tennessee Oncology

    RECRUITING

    Nashville, Tennessee, 37203, United States

  • The Cancer Institute Hospital of JFCR

    RECRUITING

    Tokyo, 135 8550, Japan

  • University Of Minnesota

    RECRUITING

    Minneapolis, Minnesota, 55455, United States

  • University of Colorado Anschutz Medical Campus

    RECRUITING

    Aurora, Colorado, 80045, United States

Conditions

Explore the condition pages connected to this study.